Company / Finance

DANAHER CORP /DE/

DHR · NYSE

Danaher and Agilent both sell into durable lab workflows, but the winner depends on recurring mix, margin quality, and cash conversion.

Latest ReportJun 5, 2026Danaher Vs Agilent: Which Life Science Giant Wins The Recurring Revenue War?View report ->Total Reports2Published reportsView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->
Admin-only preview

Valuation is limited to admins for now.

The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.